tirzepatide versus semaglutide once weekly vs Tirzepatide: Which GLP-1 Wins for Weight Loss? SURPASS 2: Tirzepatide Versus Once-Weekly

This population might benefit most from injections if dietary improvements dont do enough to raise levels

Follow this procedure every single time, and you'll protect the integrity of your investment and the validity of your work

Ertugliflozin The Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes Trial (VERTIS CV) was a multicentre RCT in which 8246 patients with T2D and atherosclerotic cardiovascular disease were randomized to receive either 5 mg or 15 mg of ERTU versus placebo once a day

GLP-1 based therapies:differential effects on fasting and postprandial glucose

Urine was aliquoted into 5 tubes of 1 mL and stored at 80 C until batch analysis